$20.08
-0.1-0.48%
At close: -
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
iShares Genomics Immunology and Healthcare ETF Stock Price, Quotes and Forecasts
IDNAARCA
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
106.75M
Fund Score
iShares Genomics Immunology and Healthcare ETF Price, Quotes and Forecasts | ARCA:IDNA | Benzinga
Explore iShares Genomics Immunology and Healthcare ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IDNA.
| Open | $19.88 |
| High | $20.10 |
| 52 Wk High | $25.80 |
| AUM | 106.75M |
| Dividend | $0.26 |
| Ex-Div Date | Dec 17, 2024 |
| Volume | 11.65K |
| Market Cap | $29.50B |
| Mgmt Fee | 0.47% |
| P/E Ratio | 21.13 |
| Prev. Close | $20.18 |
| Low | $19.88 |
| 52 Wk Low | $17.26 |
| Shares Out | 5.85M |
| Yield | 1.30% |
| Div. Freq | S |
| Avg. Volume Daily | 26.17K |
| Beta | 1.05 |
| Avg. Expense Ratio | 0.47% |
| P/B Ratio | 2.96 |
Recent News
FAQ
Q
How do I buy iShares Genomics Immunology and Healthcare ETF (IDNA) stock?
A
You can purchase shares of iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) through any online brokerage.
Q
Who are iShares Genomics Immunology and Healthcare ETF (IDNA) competitors?
A
There are no as such competitors for iShares Genomics Immunology and Healthcare ETF.
Q
What is the forecast, or price target, for iShares Genomics Immunology and Healthcare ETF (IDNA) stock?
A
There is no analysis for iShares Genomics Immunology and Healthcare ETF to provide a consensus price target.
Q
What is the current price for iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
The stock price for iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA) is $19.64 last updated April 30, 2025 at 9:00 AM EDT.
Q
Does iShares Genomics Immunology and Healthcare ETF (IDNA) pay a dividend?
A
There are no upcoming dividends for iShares Genomics Immunology and Healthcare ETF.
Q
When is iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) reporting earnings?
A
iShares Genomics Immunology and Healthcare ETF does not have any upcoming earnings scheduled.
Q
Is iShares Genomics Immunology and Healthcare ETF (IDNA) going to split?
A
There is no upcoming split for iShares Genomics Immunology and Healthcare ETF.
| Open | $19.88 |
| High | $20.10 |
| 52 Wk High | $25.80 |
| AUM | 106.75M |
| Dividend | $0.26 |
| Ex-Div Date | Dec 17, 2024 |
| Volume | 11.65K |
| Market Cap | $29.50B |
| Mgmt Fee | 0.47% |
| P/E Ratio | 21.13 |
| Prev. Close | $20.18 |
| Low | $19.88 |
| 52 Wk Low | $17.26 |
| Shares Out | 5.85M |
| Yield | 1.30% |
| Div. Freq | S |
| Avg. Volume Daily | 26.17K |
| Beta | 1.05 |
| Avg. Expense Ratio | 0.47% |
| P/B Ratio | 2.96 |
About iShares Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Jun 11, 2019 |
| Managers | Paul Whitehead Greg Savage Jennifer Hsui |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
Investment Policy
The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| SM | Roche Holding A.G. | 5.31% |
| GILD | Gilead Sciences Inc | 4.62% |
| SRPT | Sarepta Therapeutics I... | 4.53% |
| RVMD | Revolution Medicines I... | 4.44% |
| INCY | Incyte Corp. | 4.30% |
| REGN | Regeneron Pharmaceutic... | 4.23% |
| EXEL | Exelixis Inc | 5.19% |
| TK | Takeda Pharmaceutical ... | 4.93% |
| PA | Sanofi SA | 5.31% |
| HK | Beigene, Ltd. | 6.07% |
| SWTX | Springworks Therapeuti... | 4.81% |
| LN | GSK plc | 5.49% |
| CO | Genmab A.S. | 4.58% |
| MRK | Merck & Co. Inc. | 4.26% |
| FF | Biontech Se | 4.06% |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved